why choose us

First received: September 28, 2023

Clinical Trial: A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Parkinson's Disease Psychosis

Study Type: INTERVENTIONAL


Official Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of 34 mg pimavanserin compared to placebo in patients with Parkinson's disease psychosis (PDP).

Read more